Accelerating drug discovery with analytical R&D solutions

In this interview, Thermo Fisher Scientific discusses how to accelerate drug discovery through analytical R&D.

Abbott CEO sees ‘mass market potential’ for CGMs

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. By the numbers Q3 sales: $10.64 billion

October 16, 2024

Breast Cancer Now funds researchers to investigate targeted radiotherapy for metastatic breast cancer in the brain

Researchers are trialing a new type of targeted radiotherapy to treat secondary breast cancer tumors in the brain, thanks to new funding from Breast Cancer

March 18, 2024

23andMe’s independent board directors resign

Dive Brief: 23andMe’s independent board directors resigned on Tuesday amid uncertainty about the DNA testing company’s future. In a letter to CEO Anne Wojcicki, the

September 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.